N@N

Nicole Gabreski Maintained (TVTX) at Hold with Increased Target to $11 on, Jan 18th, 2024

Nicole Gabreski of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Hold with Increased Target from $10 to $11 on, Jan 18th, 2024.

Nicole has made no other calls on TVTX in the last 4 months.

There are 10 other peers that have a rating on TVTX. Out of the 10 peers that are also analyzing TVTX, 3 agree with Nicole's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Alex Thompson of "Stifel" Maintained at Hold with Increased Target to $10 on, Monday, December 18th, 2023
• Mohit Bansal of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $8 on, Friday, September 22nd, 2023
• Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Thursday, September 21st, 2023

These are the ratings of the 7 analyists that currently disagree with Nicole

---

• Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $20 on, Friday, December 15th, 2023
• Carly Kenselaar of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $10 on, Tuesday, December 5th, 2023
• Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $12 on, Friday, September 29th, 2023
• Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $14 on, Friday, September 22nd, 2023
• Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $12 on, Friday, September 22nd, 2023
• Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $27 on, Friday, September 22nd, 2023
• Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 22nd, 2023